Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
23.27Price to Sales
VS
Market
Sector
Industry
History
$ 27.98Close
$ 6.28 - $ 27.98 52-Week Range
Ticker Information
Ticker
NTLACompany Name
INTELLIA THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQINTELLIA THERAPEUTICS INC - Price to Sales Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
NTLA - P/S Historical data
| Date | Market Capitalization | Price to Sales | Revenues |
|---|---|---|---|
| 6/30/2025 | $ 1.23B | 23.27 | $ 52.86M |
| 3/31/2025 | $ 857.67M | 18.82 | $ 45.57M |
| 12/31/2024 | $ 1.12B | 19.42 | $ 57.88M |
| 9/30/2024 | $ 1.63B | 37.82 | $ 43.09M |
| 6/30/2024 | $ 2.27B | 49.46 | $ 45.97M |
| 3/31/2024 | $ 2.4B | 45.59 | $ 52.6M |
| 12/31/2023 | $ 2.61B | 72.01 | $ 36.27M |
| 9/30/2023 | $ 2.24B | 43.18 | $ 51.77M |
| 6/30/2023 | $ 3.46B | 65.22 | $ 53.04M |
| 3/31/2023 | $ 3.85B | 71.95 | $ 53.48M |
Key Performance Insights, Last 5 Years
- INTELLIA THERAPEUTICS INC's latest trailing twelve months (TTM) P/S stands at 26.99.
- Over the past 5 years, INTELLIA THERAPEUTICS INC's average P/S has been 92.35.
- The median P/S for INTELLIA THERAPEUTICS INC during this period was 68.21
- INTELLIA THERAPEUTICS INC reached its highest P/S over the past 5 years at 372.01.
- The lowest P/S recorded by INTELLIA THERAPEUTICS INC in the same timeframe 18.82
INTELLIA THERAPEUTICS INC's P/S vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
P/S Benchmarks
Similar metrics to Revenues:
- Price to Free Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Free Cash Flow [FCF].
- Price to Operating Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Operating Cash Flow [NCFO].
- Price to Book - [Calculation] Measures a company’s [MarketCap] in relation to its [Equity] which is the value of [Assets] minus [Liabilities].
- Enterprise Value over Free Cash Flow - [Calculation] Measures a company’s Enterprise Value [EV] in relation to its Free Cash Flow [FCF].
- Free Cash Flow Yield - [Calculation] The Free Cash Flow Yield, also known as the inverse of the Price to Free Cash Flow ratio [PFCF], expresses a company’s Free Cash Flow [FCF] as a percentage of [MarketCap.
Definition of Price to Sales
[Calculation] Measures a company’s [MarketCap] in relation to its [Revenue].Market Cap / Revenues
(=) P/S P/S for INTELLIA THERAPEUTICS INC is calculated as follows: Market Cap [ $ 1.68B ] / Revenues [ $ 62.34M ]
(=) P/S [ 26.99 ] NTLA - Price to Sales, Last 5 years
18.82
Minimum
Mar 31, 2025
372.01
Maximum
Sep 30, 2021
92.35
Average
68.21
Median
P/S Benchmark AnalysisMarket
The chart above depicts the distribution of P/S for companies in the Total Stock Market. The average P/S of the companies is 2.62 with a standard deviation of 2.38.
The following table provides additional summary stats:
P/S in the Market:
| filtered constituents | 3.42K |
|---|---|
| min | 0 |
| max | 11.15 |
| average | 2.62 |
| median | 1.97 |
| std | 2.38 |